Anoro Ellipta for COPD: Uses, Side Effects, and Cost-Saving Options
Anoro Ellipta (umeclidinium/vilanterol) is a prescription medication designed to help people with chronic obstructive pulmonary disease (COPD) breathe easier. This daily inhaler combines two powerful bronchodilators that work together to open airways and reduce COPD symptoms.
Shop Medications
,If you or someone you love has been diagnosed with COPD, understanding how Anoro Ellipta works and whether it might be right for your treatment plan can help you make informed decisions about your care.
In This Article
- What Is Anoro Ellipta?
- How Does Anoro Ellipta Work?
- Who Can Use Anoro Ellipta?
- Proper Use and Dosing
- Common Side Effects
- Serious but Rare Side Effects
- Drug Interactions and Precautions
- Cost Considerations and Affordable Options
- Monitoring Your Treatment
- Living with COPD and Anoro Ellipta
- When to Contact Your Doctor
- References
What Is Anoro Ellipta?
Anoro Ellipta is a combination inhaler that contains two active ingredients: umeclidinium bromide and vilanterol trifenatate. These medications belong to different classes of bronchodilators, which are drugs that help open the airways in your lungs.
Umeclidinium is what doctors call a LAMA, or long-acting muscarinic antagonist. Vilanterol is a LABA, or long-acting beta2-adrenergic agonist. When used together, these two ingredients provide 24-hour relief from COPD symptoms with just one daily dose.
The FDA has approved Anoro Ellipta specifically for the long-term maintenance treatment of COPD, including chronic bronchitis and emphysema. It is not approved for treating asthma or for use as a rescue inhaler during sudden breathing problems.
How Does Anoro Ellipta Work?
COPD makes it hard to breathe because the airways in your lungs become narrow and inflamed. The two ingredients in Anoro Ellipta work through different mechanisms to help keep your airways open.
Umeclidinium blocks certain receptors in the smooth muscle around your airways. When these receptors are blocked, the muscles relax, and the airways stay open longer. This helps reduce the feeling of breathlessness that many people with COPD experience.
Vilanterol works by activating different receptors that also cause the airway muscles to relax. It also helps reduce inflammation in the lungs. Together, these two medications provide more comprehensive relief than either ingredient would provide alone.
The combination starts working within minutes of inhalation, but it may take several weeks of regular use to experience the full benefits. This is why Anoro Ellipta is considered a maintenance medication rather than a rescue treatment.
Who Can Use Anoro Ellipta?
Anoro Ellipta is prescribed for adults aged 18 and older who have been diagnosed with COPD. Your doctor will typically recommend this medication if you have moderate to severe COPD symptoms that are not adequately controlled with other treatments.
Before prescribing Anoro Ellipta, your healthcare provider will confirm that you have COPD and not asthma. This distinction is important because LABA medications like vilanterol can increase the risk of serious asthma-related problems, including death, when used without an inhaled corticosteroid.
Some people should not use Anoro Ellipta. These include individuals who are allergic to umeclidinium, vilanterol, or milk proteins. The medication contains lactose, which is derived from milk, so people with severe milk protein allergies should avoid this inhaler.
Proper Use and Dosing
The standard dose of Anoro Ellipta is one inhalation once daily at the same time each day. Each inhalation delivers 62.5 micrograms of umeclidinium and 25 micrograms of vilanterol.
The Ellipta inhaler is designed to be easy to use. Here are the basic steps:
- Open the cover until you hear a click.
- Breathe out fully, away from the inhaler.
- Put your lips around the mouthpiece and breathe in steadily and deeply.
- Hold your breath for about 3-4 seconds.
- Close the cover to reset the inhaler for the next dose.
It is important to use Anoro Ellipta every day, even when you feel well. Skipping doses can reduce the medication’s effectiveness and may lead to worsening COPD symptoms.
Never use more than one inhalation per day, and do not use this medication to treat sudden breathing problems. Keep a separate rescue inhaler available for emergencies.
Common Side Effects
Most people who use Anoro Ellipta tolerate it well, but like all medications, it can cause side effects. In clinical trials, the most commonly reported side effects included:
- Sore throat
- Sinus or upper respiratory tract infections
- Constipation
- Diarrhea
- Muscle spasms
These side effects are typically mild and may improve as your body adjusts to the medication. If any of these effects persist or worsen, contact your healthcare provider.
Serious but Rare Side Effects
While uncommon, Anoro Ellipta can cause more serious side effects that require immediate medical attention. These occur in less than 1% of patients but are important to recognize:
- Serious allergic reactions – including rash, swelling of face or throat, and difficulty breathing
- Eye problems – such as acute narrow-angle glaucoma, which can cause eye pain and vision changes
- Urinary retention – difficulty urinating, especially in men with enlarged prostate
- Heart problems – including fast or irregular heartbeat and high blood pressure
- Pneumonia – signs include fever, increased mucus production, and worsening cough
- Bronchospasm – sudden narrowing of the airways that can lead to trouble breathing, wheezing, cough, and chest discomfort
If you experience any of these symptoms, stop using Anoro Ellipta and seek medical care immediately.
Drug Interactions and Precautions
Before starting Anoro Ellipta, tell your doctor about all medications you are taking. Some drugs can interact with the ingredients in this inhaler, potentially affecting how it works or increasing the risk of side effects.
Medications that may interact with Anoro Ellipta include certain antidepressants, blood pressure medications, and other bronchodilators. Your doctor will need to monitor you more closely if you take any of these drugs together.
People with certain health conditions should use Anoro Ellipta with caution. These conditions include:
- Heart problems or high blood pressure
- Seizure disorders
- Thyroid problems
- Diabetes
- Kidney or liver disease
- Enlarged prostate or urinary blockage
- Glaucoma
Your healthcare provider will weigh the benefits and risks before prescribing Anoro Ellipta if you have any of these conditions.
Cost Considerations and Affordable Options
The cost of Anoro Ellipta can vary significantly depending on your insurance coverage. Without insurance, this medication can be expensive, with monthly costs often exceeding several hundred dollars.
If you are concerned about the cost of your medication, there are several strategies to explore:
Insurance coverage varies widely, so check with your plan to understand your copay or coinsurance requirements. Some plans may require you to try less expensive medications first before covering Anoro Ellipta.
For patients paying cash or those with high deductibles, Universal Drugstore offers a reliable option for accessing prescription medications at competitive prices. As a licensed pharmacy, Universal Drugstore provides safe, authentic medications while helping patients manage medication costs more effectively.
The manufacturer may also offer patient assistance programs for those who qualify based on income and insurance status. Your doctor’s office or pharmacist can help you explore these options.
Monitoring Your Treatment
Regular follow-up with your healthcare provider is essential when using Anoro Ellipta. Your doctor will want to assess how well the medication is controlling your COPD symptoms and monitor for any side effects.
During follow-up visits, be prepared to discuss:
- Changes in your breathing or COPD symptoms
- How often you need to use your rescue inhaler
- Any side effects you have experienced
- Your ability to perform daily activities
- Any other medications you are taking
Your doctor may also perform lung function tests periodically to measure how well Anoro Ellipta is working for you. These tests help determine if your current treatment plan needs any adjustments.
Living with COPD and Anoro Ellipta
While Anoro Ellipta can significantly improve COPD symptoms, it works best as part of a comprehensive treatment approach. This includes lifestyle changes that can help slow the progression of COPD and improve your quality of life.
If you smoke, quitting is the most important thing you can do for your lung health. Your healthcare provider can help you find resources and support for smoking cessation.
Regular exercise, as approved by your doctor, can help improve your breathing and overall fitness. Even light activities like walking can make a difference over time.
Avoiding lung irritants such as air pollution, dust, and strong chemical fumes can help prevent COPD flare-ups. Consider using air purifiers in your home and staying indoors during high pollution days.
Getting vaccinated against the flu and pneumonia is especially important for people with COPD, as respiratory infections can worsen symptoms and lead to serious complications.
When to Contact Your Doctor
While using Anoro Ellipta, contact your healthcare provider if you experience:
- Worsening breathing problems or COPD symptoms
- Increased need for your rescue inhaler
- Signs of infection, such as fever or a change in mucus color
- New or worsening side effects
- Difficulty using the inhaler device
Remember that Anoro Ellipta is not a rescue medication. If you have sudden, severe breathing problems, use your rescue inhaler and seek emergency medical care if symptoms do not improve quickly.
By working closely with your healthcare team and using Anoro Ellipta as prescribed, many people with COPD can achieve better symptom control and maintain a more active lifestyle. The key is consistent use of the medication combined with other COPD management strategies recommended by your doctor.
References
-
Anoro Ellipta- umeclidinium bromide and vilanterol trifenatate powder [package insert]. GlaxoSmithKline LLC. DailyMed. Last updated 6/2023. Accessed June 1, 2026.